All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
![MYELOSTAT 500MG CAPSULE_101130_1 MYELOSTAT 500MG CAPSULE_101130_1](https://assets.mrmed.in/product-images/product-images-1691403539315-437301344-MYELOSTAT%20500MG%20CAPSULE_101130_1.jpg)
![MYELOSTAT 500MG CAPSULE_101130_1 MYELOSTAT 500MG CAPSULE_101130_1](https://assets.mrmed.in/product-images/product-images-1691403539315-437301344-MYELOSTAT%20500MG%20CAPSULE_101130_1.jpg)
Myelostat 500mg Capsule
Prescription Required
Salt Composition : Hydroxyurea
Manufacturer : ZYDUS CADILA
Origin of Medicine : India
10 Capsule(s) In A Strip
Get financial assistance directly from pharma companies and cover your cost of medicines or get free medicines for the eligible patient with patient assistance programs (PAP). We provide proper guidance assistance to patients getting enrolled in the patient assistance program.
Introduction to Myelostat 500mg Capsule
Myelostat 500mg Capsule is an anticancer medication containing the active ingredient as Hydroxyurea. It is used to treat chronic myeloid leukemia (cancer of white blood cells) and polycythemia vera (cancer of red blood cells). The benefits of this medication include treating cancer by slowing down the growth and division of cancer cells and treating sickle cell anemia by reducing the frequency and severity of painful episodes and preventing organ damage. It is used to treat cervical, ovarian, and melanoma (skin cancer) and head and neck cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
It is used to treat sickle cell anemia (an inherited blood disease in which healthy red blood cells are insufficient). This medication may be used to treat other conditions not mentioned here. You need to talk to your physician if you have any blood disorders, severe anemia, kidney disorders, liver disorders, gout, leg ulcers, folic acid deficiency, or have an intolerance to some sugars before taking Myelostat 500mg Capsule.
Uses of Myelostat 500mg Capsule
Myelostat 500mg Capsule is approved for the following conditions:
- Ovarian cancer
- Polycythemia vera
- Chronic myeloid leukemia
- Cervical cancer
- Head and neck cancer
- Sickle cell anemia
Therapeutic Effects of Myelostat 500mg Capsule
In cancer, Myelostat 500mg Capsule works by slowing down the growth and division of cancer cells, which can help to shrink tumors and prevent the spread of cancer to other parts of the body. This can lead to a reduction in the size and number of tumors, which may improve symptoms and increase survival rates.
In sickle cell anemia, this medication works by increasing the production of fetal hemoglobin, which can help to prevent the abnormal shaping of red blood cells. This can reduce the frequency and severity of painful episodes, prevent damage to organs, and improve the overall quality of life. It also reduces the need for blood transfusions and hospitalizations. It prevents complications such as stroke, acute chest syndrome, and pulmonary hypertension.
Interaction of Myelostat 500mg Capsule with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Myelostat 500mg Capsule and reduce effectiveness by causing undesirable side effects.
More Information about Myelostat 500mg Capsule
- Myelostat 500mg Capsule should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
- Keep in the original package.
- Keep away from light, moisture, and heat.
- Keep it away from children and pets.
How to consume Myelostat 500mg Capsule
Myelostat 500mg Capsule should be taken exactly as prescribed by a healthcare provider. It is typically taken orally in the form of a capsule or tablet, usually once a day or as directed by the healthcare provider. The medication should be taken with a full glass of water and can be taken with or without food, depending on the individual's preference and tolerability.
If a dose is missed, it should be taken as soon as possible unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed. It is important not to take a double dose to make up for a missed dose.
Safety Advices for Myelostat 500mg Capsule
Pregnancy
Myelostat 500mg Capsule is not safe for use during pregnancy because it can harm to developing baby. You need to tell your physician if you are pregnant or planning to get pregnant before taking this medicine.
Breast Feeding
It is not safe to take Myelostat 500mg Capsules while breastfeeding. It has been shown to pass into breast milk, and its affects the nursing infant. Because of this, women who are taking this medication should avoid breastfeeding.
Lungs
Myelostat 500mg Capsule can cause lung toxicity, although this is a rare side effect. If you have pre-existing lung problems or a history of radiation therapy to the lungs, you should tell your healthcare provider before taking this medication.
Liver
Myelostat 500mg Capsule can potentially cause liver damage, although this is also a rare side effect. People who have pre-existing liver disease are at a higher risk. You need to tell your physician if you have any liver disorders before taking it, as this medication should be used with caution in liver disorder patients.
Alcohol
Alcohol consumption can negatively affect the immune system and may interfere with the effectiveness of cancer therapies. So it is recommended to avoid taking alcohol while taking Myelostat 500mg Capsule.
Driving
Patients receiving Myelostat 500mg Capsule should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
Side Effects of Myelostat 500mg Capsule
Like all medications, Myelostat 500mg Capsule can cause side effects, although not everyone who takes it will experience them.
Serious:
- Bone marrow suppression (decreased blood cell count)
- Skin reactions (rash, itching, and skin ulcers)
- Stevens-Johnson syndrome (life-threatening skin reaction)
- Tumor lysis syndrome (occur when large numbers of cancer cells are killed rapidly)
- Liver damage (jaundice, dark urine, pale stools, nausea, vomiting, and abdominal pain)
- Lung toxicity (shortness of breath, cough, fever, and chest pain)
Common:
- Nausea
- Vomiting
- Diarrhea
- Loss of appetite
- Mouth sores
- Headache
- Dizziness
- Fatigue
- Skin darkening
- Hair loss or thinning
- Nail changes
- Constipation
Word of Advice
Myelostat 500mg Capsule is a powerful medication that can have potentially serious side effects. Therefore, following your healthcare provider's instructions for taking the medication and reporting any side effects or changes in your health is important. Women taking contraceptives should inform a doctor before the treatment. If you are a woman who could become pregnant, use effective birth control during the treatment and for at least three months after the last dose. Tell your doctor if you have any liver, lung, or kidney disease before taking medication. You should use sun protection while taking this medication. It is recommended that patients undergoing cancer treatment eat a diet rich in fruits, vegetables, whole grains, and lean proteins and limit their intake of processed and high-fat foods. Drinking plenty of water and staying hydrated are also important.
FAQs
Q 1. Does Myelostat 500mg Capsule interact with other medications?
Yes, Myelostat 500mg Capsule can interact with other medications, including blood thinners, vaccines, and certain antibiotics.
Q 2. Can Myelostat 500mg Capsule cause skin cancer?
There is a small risk that long-term use of Myelostat 500mg Capsule may increase the risk of developing skin cancer, particularly squamous cell carcinoma. People taking this medication should avoid prolonged exposure to sunlight and use protective clothing and sunscreen to reduce their risk of developing skin cancer.
Q 3. Can Myelostat 500mg Capsule be used in children?
Yes, Myelostat 500mg Capsule can be used in children with certain medical conditions, such as sickle cell disease and certain types of leukemia. However, the dosage and administration may differ from that used in adults, and a healthcare provider should closely monitor the use of this medication in children.
Q 4. Can Myelostat 500mg Capsule be used to treat COVID-19?
There is currently no evidence to support the use of Myelostat 500mg Capsules in the treatment of COVID-19. It is used primarily to treat certain types of cancer and blood disorders.
Q 5. Can Myelostat 500mg Capsule be used as a preventive measure for sickle cell disease complications?
Yes, Myelostat 500mg Capsule is sometimes used as a preventive measure to reduce the frequency and severity of complications in people with sickle cell disease. It can help increase fetal hemoglobin production, preventing sickle cell crises and other complications.
Q 6. How long does it take for Myelostat 500mg Capsule to start working?
The onset of action of Myelostat 500mg Capsule may vary depending on the condition being treated. In some cases, it may take several weeks or months for the full therapeutic effect to be achieved. Healthcare providers will monitor the individual's response to treatment and adjust the dosage as needed.
Fact Box of Myelostat 500mg Capsule
Molecule name: Hydroxyurea | Therapeutic class: Anticancer |
Pharmacological class: Antimetabolite | Indications: 1. Ovarian cancer 2. Polycythemia vera 3. Chronic myeloid leukemia 4. Cervical cancer 5. Head and neck cancer 6. Sickle cell anemia |
References
- Bristol-Myers Squibb Pharmaceuticals Unlimited Company, Electronic medicines compendium (EMC), [Revised on August 2021] [ Accessed on 17 April 2023], https://www.medicines.org.uk/emc/files/pil.271.pdf
- Bristol-Myers Squibb Company, US Food and Drug Administration, [Revised on March 2016] [ Accessed on 17th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016295Orig1s047,s048Lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1721.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 868.
- Rohit Kumar Agarwal et al; Hydroxyurea in Sickle Cell Disease: Drug Review; Indian Journal of Hematology & Blood Transfusion; Published on June 2014; Accessed on 17 April 2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022916/#__ffn_sectitle
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.